PPAR

Sigaling Pathway Map

Research Area

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S2505 Rosiglitazone maleate <1 mg/mL 94 mg/mL <1 mg/mL
S2556 Rosiglitazone <1 mg/mL 71 mg/mL <1 mg/mL
S2915 GW9662 <1 mg/mL 55 mg/mL <1 mg/mL
S2871 T0070907 <1 mg/mL 26 mg/mL <1 mg/mL
S2590 Pioglitazone <1 mg/mL 15 mg/mL <1 mg/mL
S4708 Palmitoylethanolamide <1 mg/mL 59 mg/mL 59 mg/mL
S4527 Fenofibric acid 63 mg/mL 63 mg/mL 63 mg/mL
S7767 AZ6102 <1 mg/mL 85 mg/mL <1 mg/mL
S8029 WY-14643 (Pirinixic Acid) <1 mg/mL 65 mg/mL 52 mg/mL
S8025 GSK3787 <1 mg/mL 79 mg/mL <1 mg/mL
S8020 GW0742 <1 mg/mL 94 mg/mL 44 mg/mL
S1729 Gemfibrozil <1 mg/mL 50 mg/mL 50 mg/mL
S2665 Ciprofibrate <1 mg/mL 58 mg/mL 58 mg/mL
S4159 Bezafibrate <1 mg/mL 72 mg/mL 18 mg/mL
S4207 Clofibric Acid <1 mg/mL 43 mg/mL 43 mg/mL
S1794 Fenofibrate <1 mg/mL 72 mg/mL 46 mg/mL
S2075 Rosiglitazone HCl <1 mg/mL 79 mg/mL 79 mg/mL
S7484 FH535 <1 mg/mL 72 mg/mL <1 mg/mL

Isoform-specific Inhibitors

Catalog No. Information Product Use Citations Product Validations
S2871

T0070907

T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM in a cell-free assay, with a >800-fold selectivity over PPARα and PPARδ.

S4527New

Fenofibric acid

Fenofibric acid is a fibrate that acts as a lipid-lowering agent, decreasing low-density lipoprotein cholesterol and triglycerides.

S7767New

AZ6102

AZ6102 is a potent TNKS1/2 inhibitor that has 100-fold selectivity against other PARP family enzymes and shows IC50 of 5 nM for Wnt pathway inhibition in DLD-1 cells.

S7484

FH535

FH535 is a Wnt/β-catenin signaling inhibitor and also a dual PPARγ and PPARδ antagonist.

S2505

Rosiglitazone maleate

Rosiglitazone, a member of the thiazolidinedione class of antihyperglycaemic agents, is a high-affinity selective agonist of the peroxisome proliferator-activated receptor-γ with IC50 of 42 nM.

S2556

Rosiglitazone

Rosiglitazone is a potent antihyperglycemic agent and a potent thiazolidinedione insulin sensitizer with IC50 of 12, 4 and 9 nM for rat, 3T3-L1 and human adipocytes, respectively. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha-binding action.

S2590

Pioglitazone

Pioglitazone is a selective peroxisome proliferator-activated receptor-gamma (PPARγ) agonist, used to treat diabetes; A weak activator for full-length hPPARα, but not full-length hPPARδ.

S8020

GW0742

GW0742 is a potent and highly selective PPARβ/δ agonist, with IC50 of 1 nM, with 1000-fold selectivity over hPPARα and hPPARγ.

S2665

Ciprofibrate

Ciprofibrate is a peroxisome proliferator-activated receptor agonist.

S4159

Bezafibrate

Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.

S4207

Clofibric Acid

Clofibric acid is a PPARα agonist and hypolipidemic agent.

S1794

Fenofibrate

Fenofibrate (Tricor, Trilipix) is a compound of the fibrate class and fibric acid derivative.

S2075

Rosiglitazone HCl

Rosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.

S4708New

Palmitoylethanolamide

Palmitoylethanolamide(PEA) is an endogenous fatty acid amide and selectively activates PPAR-α in vitro with an EC50 value of 3.1±0.4 μM.

S8029

WY-14643 (Pirinixic Acid)

WY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPARα with EC50 of 1.5 μM.

S1729

Gemfibrozil

Gemfibrozil is an activator of peroxisome proliferator-activated receptor-alpha (PPARα), used for the treatment of hypercholesterolemia and hypertriglyceridemia.

S2915

GW9662

GW9662 is a selective PPAR antagonist for PPARγ with IC50 of 3.3 nM in a cell-free assay, with at least 100 to 1000-fold functional selectivity in cells with PPARγ versus PPARα and PPARδ.

S8025

GSK3787

GSK3787 is as a selective and irreversible antagonist of PPARδ with pIC50 of 6.6, with no measurable affinity for hPPARα or hPPARγ.

Catalog No. Information Product Use Citations Product Validations
S2871

T0070907

T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM in a cell-free assay, with a >800-fold selectivity over PPARα and PPARδ.

S4527New

Fenofibric acid

Fenofibric acid is a fibrate that acts as a lipid-lowering agent, decreasing low-density lipoprotein cholesterol and triglycerides.

S7767New

AZ6102

AZ6102 is a potent TNKS1/2 inhibitor that has 100-fold selectivity against other PARP family enzymes and shows IC50 of 5 nM for Wnt pathway inhibition in DLD-1 cells.

S7484

FH535

FH535 is a Wnt/β-catenin signaling inhibitor and also a dual PPARγ and PPARδ antagonist.

Catalog No. Information Product Use Citations Product Validations
S4708New

Palmitoylethanolamide

Palmitoylethanolamide(PEA) is an endogenous fatty acid amide and selectively activates PPAR-α in vitro with an EC50 value of 3.1±0.4 μM.

S8029

WY-14643 (Pirinixic Acid)

WY 14643 (Pirinixic Acid) is a potent peroxisome proliferator and activator of PPARα with EC50 of 1.5 μM.

S1729

Gemfibrozil

Gemfibrozil is an activator of peroxisome proliferator-activated receptor-alpha (PPARα), used for the treatment of hypercholesterolemia and hypertriglyceridemia.

Catalog No. Information Product Use Citations Product Validations
S2915

GW9662

GW9662 is a selective PPAR antagonist for PPARγ with IC50 of 3.3 nM in a cell-free assay, with at least 100 to 1000-fold functional selectivity in cells with PPARγ versus PPARα and PPARδ.

2016, 6:36382

2016, 316:17-26

2015, 43(2):310-324

S8025

GSK3787

GSK3787 is as a selective and irreversible antagonist of PPARδ with pIC50 of 6.6, with no measurable affinity for hPPARα or hPPARγ.

2016, 10.1016/j.neuropharm.2016.10.022

Catalog No. Information Product Use Citations Product Validations
S2505

Rosiglitazone maleate

Rosiglitazone, a member of the thiazolidinedione class of antihyperglycaemic agents, is a high-affinity selective agonist of the peroxisome proliferator-activated receptor-γ with IC50 of 42 nM.

2015, 285(1):51-60

2016, 61:162-8

2013, 2(3):215-26

S2556

Rosiglitazone

Rosiglitazone is a potent antihyperglycemic agent and a potent thiazolidinedione insulin sensitizer with IC50 of 12, 4 and 9 nM for rat, 3T3-L1 and human adipocytes, respectively. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha-binding action.

2014, 95(4):587-98

2015, 285(1):51-60

S2590

Pioglitazone

Pioglitazone is a selective peroxisome proliferator-activated receptor-gamma (PPARγ) agonist, used to treat diabetes; A weak activator for full-length hPPARα, but not full-length hPPARδ.

2016, 311(4):E763-E771

2016, 53(2):443-52

2014, 42(3):318-22

S8020

GW0742

GW0742 is a potent and highly selective PPARβ/δ agonist, with IC50 of 1 nM, with 1000-fold selectivity over hPPARα and hPPARγ.

2016, 10.1016/j.neuropharm.2016.10.022

S2665

Ciprofibrate

Ciprofibrate is a peroxisome proliferator-activated receptor agonist.

S4159

Bezafibrate

Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.

S4207

Clofibric Acid

Clofibric acid is a PPARα agonist and hypolipidemic agent.

S1794

Fenofibrate

Fenofibrate (Tricor, Trilipix) is a compound of the fibrate class and fibric acid derivative.

S2075

Rosiglitazone HCl

Rosiglitazone HCl is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.

2014, 95(4):587-98

2015, 285(1):51-60